17692718

Source:http://linkedlifedata.com/resource/pubmed/id/17692718

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001617, umls-concept:C0001675, umls-concept:C0004048, umls-concept:C0034656, umls-concept:C0054201, umls-concept:C0150108, umls-concept:C0205081, umls-concept:C0205653, umls-concept:C1382107, umls-concept:C1960048, umls-concept:C1967611, umls-concept:C2603343
pubmed:issue	6
pubmed:dateCreated	2007-8-13
pubmed:abstractText	Nebulized budesonide inhalation suspension (BIS) is approved in the United States for children with asthma aged 1 to 8 years.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7706726
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Adrenal Cortex Hormones, http://linkedlifedata.com/resource/pubmed/chemical/Bronchodilator Agents, http://linkedlifedata.com/resource/pubmed/chemical/Budesonide, http://linkedlifedata.com/resource/pubmed/chemical/Powders
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	0149-2918
pubmed:author	pubmed-author:MurphyKevinK, pubmed-author:NoonanMichaelM, pubmed-author:SilkoffPhilip EPE, pubmed-author:UryniakThomasT
pubmed:issnType	Print
pubmed:volume	29
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1013-26
pubmed:meshHeading	pubmed-meshheading:17692718-Administration, Inhalation, pubmed-meshheading:17692718-Adolescent, pubmed-meshheading:17692718-Adrenal Cortex Hormones, pubmed-meshheading:17692718-Adult, pubmed-meshheading:17692718-Aged, pubmed-meshheading:17692718-Analysis of Variance, pubmed-meshheading:17692718-Asthma, pubmed-meshheading:17692718-Bronchodilator Agents, pubmed-meshheading:17692718-Budesonide, pubmed-meshheading:17692718-Child, pubmed-meshheading:17692718-Dose-Response Relationship, Drug, pubmed-meshheading:17692718-Female, pubmed-meshheading:17692718-Forced Expiratory Volume, pubmed-meshheading:17692718-Humans, pubmed-meshheading:17692718-Male, pubmed-meshheading:17692718-Metered Dose Inhalers, pubmed-meshheading:17692718-Middle Aged, pubmed-meshheading:17692718-Nebulizers and Vaporizers, pubmed-meshheading:17692718-Powders, pubmed-meshheading:17692718-Severity of Illness Index, pubmed-meshheading:17692718-Sex Factors, pubmed-meshheading:17692718-Single-Blind Method, pubmed-meshheading:17692718-Time Factors, pubmed-meshheading:17692718-Treatment Outcome
pubmed:year	2007
pubmed:articleTitle	A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
pubmed:affiliation	Midwest Children's Chest Physicians, Omaha, Nebraska 68114, USA. murphknsc@aol.com
pubmed:publicationType	Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study